www.akampion.de Gehe zur Webseite

akampion we create visibility

Ermittelte Webseitenkriterien und Platzierungen
1
Sprache/Land: Flagge von EN EN
Webseiten Geschwindigkeit:0.414 Sekunden
Bewertung Besucher 8 / Tag Wert 100 € SEO Score 44/100 NEU!
Kein Besucheraufkommen zu dieser Domain gefunden.

Wichtigste Keywords

InDex Pharmaceuticals drug candidate Kappaproct Phase III license agreement integrated amplification Australian patent office Unyvero core technology Curetis rights Almirall European detection

Serverdaten

Serverstandort: Deutschland
Die IP-Adresse lautet 82.165.209.215.

DNS-Daten

HostKlasseTypZiel
akampion.deINA89.31.143.10
akampion.deINSOAserver1-ns1.udagdns.net
akampion.deINNSserver1-ns2.udagdns.net
akampion.deINNSserver1-ns1.udagdns.net
akampion.deINNSserver1-ns3.udagdns.net
akampion.deINMXmx00.udag.de
akampion.deINMXmx01.udag.de

Server-Ping

PING akampion.de (89.31.143.10) 56(84) bytes of data.
64 bytes from 89.31.143.10: icmp_req=1 ttl=55 time=3.62 ms
64 bytes from 89.31.143.10: icmp_req=2 ttl=55 time=3.21 ms
64 bytes from 89.31.143.10: icmp_req=3 ttl=55 time=3.19 ms
64 bytes from 89.31.143.10: icmp_req=4 ttl=55 time=3.18 ms

--- akampion.de ping statistics ---
4 packets transmitted, 4 received, 0% packet loss, time 600ms
rtt min/avg/max/mdev = 3.183/3.303/3.620/0.187 ms
Die Seite hat eine Ladezeit von 0.414 Sekunden. Die Verbinungszeit zum Server beträgt 3.62ms.

HTTP-Header

HTTP-TagWert
http_versionHTTP/1.1
statuscode200
dateFri, 04 Apr 2014 09:59:53 GMT
serverApache
x-powered-byPHP/5.2.17
x-pingbackhttp://akampioneer.com/xmlrpc.php
set-cookiePHPSESSID=b265d63735175178b89a8a4b7ae6cd20; path=/
transfer-encodingchunked
content-typetext/html; charset=UTF-8

Meta Tags

Meta-TagWert
authorwww.akampion.com
publisherwww.akampion.com
copyrightwww.akampion.com
keywordsCorporate Communications, Reputation Management, Consulting, Strategy, Investor Relations, Public Re...
audienceAlle
page-typeCorporate Communications, Service, Consulting
revisit-after14 days
robotsindex,follow
content-languageEN-US
content-typetext/html; charset=utf-8

Externe Links

AnchorURL
.bloghttp://www.akampioneer.com
Company News: InDex Pharmaceuticals and Almirall enter into a license agreement for European rights of the phase III drug candidate Kappaproct®http://akampioneer.com/company-news/company-news-index-pharmaceuticals-and-almirall-enter-...
InDex Pharmaceuticalshttp://www.indexpharmab.com/index.html
Almirallhttp://www.almirall.com/en/
Company News: Curetis Obtains Key Patent for Unyvero™ Technologyhttp://akampioneer.com/company-news/company-news-curetis-obtains-key-patent-for-unyvero%e2...
Curetis AG,http://www.curetis.com
follow us on twitterhttp://twitter.com/akampion
Letzte Aktualisierung: 04.04.2014 11:57